Can a digital pen “revolutionise” Parkinson’s diagnosis?

News

Author: Sophie BatesPublished: 23 January 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Parkinson's diagnosis pen

A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.

The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.

Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.

Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.

Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”

To read more on this topic click here.


Read more:

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Go Back

Share this story

Comments


Related articles


Baked salmon garnished with asparagus and tomatoes with herbs

Recipes & Nutrition

Why you need more vitamin B3 in your diet

Discover the added value of vitamin B3 for Parkinson’s patients

READ MORE
Parkinson's in the news: December

Global update

Parkinson’s in the news: December

A roundup of Parkinson’s news stories in December

READ MORE
arol da Barra - Salvador - Bahia – Brasil

In my country

Could physical therapy be the future of specialised Parkinson’s care in Brazil?

Filling the physical therapy gaps in Brazil's healthcare system

READ MORE